, Tracking Stock Market Picks
Enter Symbol:
Amphastar Pharmaceuticals Inc. (AMPH) [hlAlert]

down 34.88 %

American Physicians Service Group, Inc. (AMPH) rated Outperform with price target $30 by Oppenheimer

Posted on: Monday,  Aug 17, 2009  8:25 AM ET by Oppenheimer

Oppenheimer rated Outperform Amphastar Pharmaceuticals Inc. (NASDAQ: AMPH) on 08/17/2009, when the stock price was $21.21. Since
then, Amphastar Pharmaceuticals Inc. has lost 34.89% as of 01/20/2016's recent price of $13.81.
If you would have followed this Oppenheimer's recommendation on AMPH, you would have lost 34.88% of your investment in 2347 days.

American Physicians Service Group, Inc., through its subsidiaries, provides: financial services that include management of malpractice insurance companies and brokerage and investment services to individuals and institutions; and computer systems and software packages to medical clinics, physician-hospital organizations, and medical schools.

OppenheimerFunds, Inc. has been helping investors achieve their financial goals since 1960. We are one of the nation's largest and most respected asset management companies. At OppenheimerFunds, we believe that in order for you to reach your financial goals, your investments must perform. That is why investment excellence—over the long term and across the range of our products—is our highest priority. OppenheimerFunds and its controlled affiliates offer a broad range of products and services to individuals, corporations and institutions, including mutual funds, separately managed accounts, investment management for institutions, hedge fund products, qualified retirement plans and subadvisory investment-management services.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/17/2009 8:25 AM Buy
21.21 30.00
as of 12/31/2009
1 Week up  36.83 %
1 Month up  39.65 %
3 Months up  40.92 %
1 YTD up  53.08 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy